BTA
Click for more information
0.00% 57.0¢ biota holdings limited

Hey abobo, did you see the mention of patent expiry in the...

  1. PortableAlpha
    3,045 Posts.
    clock Created with Sketch.
    26/07/09
    17:40
    Post #: 5431873
    Hey abobo, did you see the mention of patent expiry in the latest press release? I wonder if someone emailed the company after reading your postings!?

    "Biota receives a minimum 7% royalty on global sales of Relenza by GSK and holds
    patent coverage in the major markets until at least December 2014."
    BTA Price at posting: $1.88 Sentiment: Buy Disclosure: Held
    Likes Created with Sketch. 1  Upvote
    lightbulb Created with Sketch.  Great analysis
    Stroke 3 Created with Sketch. Comments Created with Sketch. Reply

  2. Top Stories

 

Featured News

MM1 Geochemical work at Newington picks up gold and copper anomalies for Midas
right-arrow Created with Sketch.
NEWS Capital raisings wrap: Brainchip, Ovanti, Lake and VHM
right-arrow Created with Sketch.
FG1 Flynn Gold flags mid-grade drill hits and always eye-catching rock chips
right-arrow Created with Sketch.
IMR Imricor raises $35M to pursue growth and expansion into Australia and NZ
right-arrow Created with Sketch.
NEWS Warren Tredrea’s weekly sports business wrap: the latest on business in sport
right-arrow Created with Sketch.
FMG Quarterly & half yearly reports: Drives Newmont up, Ampol flat, while Fortescue plunges 2.6%
right-arrow Created with Sketch.
watchlist Created with Sketch. Add BTA (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.